Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study

Background: Studies of HIV-serodiscordant couples in stable sexual relationships have provided convincing evidence that antiretroviral therapy can prevent the transmission of HIV. We aimed to quantify the preventive effect of a public-sector HIV treatment and care programme based in a community with...

Full description

Bibliographic Details
Main Authors: Alain Vandormael, MS, Prof. Marie-Louise Newell, PhD, Till Bärnighausen, MD, Prof. Frank Tanser, PhD
Format: Article
Language:English
Published: Elsevier 2014-04-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X1470018X
_version_ 1818144211305758720
author Alain Vandormael, MS
Prof. Marie-Louise Newell, PhD
Till Bärnighausen, MD
Prof. Frank Tanser, PhD
author_facet Alain Vandormael, MS
Prof. Marie-Louise Newell, PhD
Till Bärnighausen, MD
Prof. Frank Tanser, PhD
author_sort Alain Vandormael, MS
collection DOAJ
description Background: Studies of HIV-serodiscordant couples in stable sexual relationships have provided convincing evidence that antiretroviral therapy can prevent the transmission of HIV. We aimed to quantify the preventive effect of a public-sector HIV treatment and care programme based in a community with poor knowledge and disclosure of HIV status, frequent migration, late marriage, and multiple partnerships. Specifically, we assessed whether an individual's hazard of HIV acquisition was associated with antiretroviral therapy coverage among household members of the opposite sex. Methods: In this prospective cohort study, we linked patients' records from a public-sector HIV treatment programme in rural KwaZulu-Natal, South Africa, with population-based HIV surveillance data collected between 2004 and 2012. We used information about coresidence to construct estimates of HIV prevalence and antiretroviral therapy coverage for each household. We then regressed the time to HIV seroconversion for 14 505 individuals, who were HIV-uninfected at baseline and individually followed up over time regarding their HIV status, on opposite-sex household antiretroviral therapy coverage, controlling for household HIV prevalence and a range of other potential confounders. Findings: 2037 individual HIV seroconversions were recorded during 54 845 person-years of follow-up. For each increase of ten percentage points in opposite-sex household antiretroviral therapy coverage, the HIV acquisition hazard was reduced by 6% (95% CI 2–9), after controlling for other factors. This effect size translates into large reductions in HIV acquisition hazards when household antiretroviral therapy coverage is substantially increased. For example, an increase of 50 percentage points in household antiretroviral therapy coverage (eg, from 20% to 70%) reduced the hazard of HIV acquisition by 26% (95% CI 9–39). Interpretation: Our findings provide further evidence that antiretroviral therapy significantly reduces the risk of onward transmission of HIV in a real-world setting in sub-Saharan Africa. Awareness that antiretroviral therapy can prevent transmission to coresident sexual partners could be a powerful motivator for HIV testing and antiretroviral treatment uptake, retention, and adherence. Funding: Wellcome Trust and National Institute of Child Health and Human Development (US National Institutes of Health).
first_indexed 2024-12-11T11:43:57Z
format Article
id doaj.art-88ac1a42c1af425eab58d923ad7e2f85
institution Directory Open Access Journal
issn 2214-109X
language English
last_indexed 2024-12-11T11:43:57Z
publishDate 2014-04-01
publisher Elsevier
record_format Article
series The Lancet Global Health
spelling doaj.art-88ac1a42c1af425eab58d923ad7e2f852022-12-22T01:08:32ZengElsevierThe Lancet Global Health2214-109X2014-04-0124e209e21510.1016/S2214-109X(14)70018-XUse of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort studyAlain Vandormael, MS0Prof. Marie-Louise Newell, PhD1Till Bärnighausen, MD2Prof. Frank Tanser, PhD3Department of Sociology, University of Minnesota, Minneapolis, MN, USAFaculties of Medicine and Social and Human Sciences, University of Southampton, Southampton, UKAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, KwaZulu-Natal, South AfricaAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, KwaZulu-Natal, South AfricaBackground: Studies of HIV-serodiscordant couples in stable sexual relationships have provided convincing evidence that antiretroviral therapy can prevent the transmission of HIV. We aimed to quantify the preventive effect of a public-sector HIV treatment and care programme based in a community with poor knowledge and disclosure of HIV status, frequent migration, late marriage, and multiple partnerships. Specifically, we assessed whether an individual's hazard of HIV acquisition was associated with antiretroviral therapy coverage among household members of the opposite sex. Methods: In this prospective cohort study, we linked patients' records from a public-sector HIV treatment programme in rural KwaZulu-Natal, South Africa, with population-based HIV surveillance data collected between 2004 and 2012. We used information about coresidence to construct estimates of HIV prevalence and antiretroviral therapy coverage for each household. We then regressed the time to HIV seroconversion for 14 505 individuals, who were HIV-uninfected at baseline and individually followed up over time regarding their HIV status, on opposite-sex household antiretroviral therapy coverage, controlling for household HIV prevalence and a range of other potential confounders. Findings: 2037 individual HIV seroconversions were recorded during 54 845 person-years of follow-up. For each increase of ten percentage points in opposite-sex household antiretroviral therapy coverage, the HIV acquisition hazard was reduced by 6% (95% CI 2–9), after controlling for other factors. This effect size translates into large reductions in HIV acquisition hazards when household antiretroviral therapy coverage is substantially increased. For example, an increase of 50 percentage points in household antiretroviral therapy coverage (eg, from 20% to 70%) reduced the hazard of HIV acquisition by 26% (95% CI 9–39). Interpretation: Our findings provide further evidence that antiretroviral therapy significantly reduces the risk of onward transmission of HIV in a real-world setting in sub-Saharan Africa. Awareness that antiretroviral therapy can prevent transmission to coresident sexual partners could be a powerful motivator for HIV testing and antiretroviral treatment uptake, retention, and adherence. Funding: Wellcome Trust and National Institute of Child Health and Human Development (US National Institutes of Health).http://www.sciencedirect.com/science/article/pii/S2214109X1470018X
spellingShingle Alain Vandormael, MS
Prof. Marie-Louise Newell, PhD
Till Bärnighausen, MD
Prof. Frank Tanser, PhD
Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study
The Lancet Global Health
title Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study
title_full Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study
title_fullStr Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study
title_full_unstemmed Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study
title_short Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004–12: a prospective cohort study
title_sort use of antiretroviral therapy in households and risk of hiv acquisition in rural kwazulu natal south africa 2004 12 a prospective cohort study
url http://www.sciencedirect.com/science/article/pii/S2214109X1470018X
work_keys_str_mv AT alainvandormaelms useofantiretroviraltherapyinhouseholdsandriskofhivacquisitioninruralkwazulunatalsouthafrica200412aprospectivecohortstudy
AT profmarielouisenewellphd useofantiretroviraltherapyinhouseholdsandriskofhivacquisitioninruralkwazulunatalsouthafrica200412aprospectivecohortstudy
AT tillbarnighausenmd useofantiretroviraltherapyinhouseholdsandriskofhivacquisitioninruralkwazulunatalsouthafrica200412aprospectivecohortstudy
AT proffranktanserphd useofantiretroviraltherapyinhouseholdsandriskofhivacquisitioninruralkwazulunatalsouthafrica200412aprospectivecohortstudy